BOT:ASX
Botanix Pharmaceuticals Ltd
0,010Â A$
0,00%
(0,00) 1K
18-noy, 16:10:16 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01Â A$
Yuqori
0,01Â A$
Past
0,01Â A$
Bozor kapitali
27,63Â mln
Oʻrtacha hajm
10,87Â mln
Hajmi
29,97Â mln
52 haftalik eng yuqori
0,15Â A$
52 haftalik eng past
0,01Â A$
Aksiya boʻyicha daromad
-0,03Â A$
Muomaladagi aksiyalar
2,76Â mlrd
Xodimlar soni
11
Ochish
0,01Â A$
Yuqori
0,01Â A$
Past
0,01Â A$
Bozor kapitali
27,63Â mln
Oʻrtacha hajm
10,87Â mln
Hajmi
29,97Â mln
52 haftalik eng yuqori
0,15Â A$
52 haftalik eng past
0,01Â A$
Aksiya boʻyicha daromad
-0,03Â A$
Muomaladagi aksiyalar
2,76Â mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
WTOP News
·
1 soat oldin
A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
The Motley Fool
·
1 soat oldin
ExxonMobil (XOM) Just Achieved Something 95% of S&P 500 (GSPC) Members Haven't Done
Hedgeye
·
8 soat oldin
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Barron's
·
4 soat oldin
Discount Retailer Stock Tops S&P 500 on Strong Holiday Outlook
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida